CClinicalTrials.gg
RecruitingNCT06623500Updated Oct 2, 2024

Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer

An observational study in Thyroid Cancer, sponsored by Shandong Provincial Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-10-02.

Sponsored by Shandong Provincial Hospital · Observational

From the registry’s dates

  • Started Jan 2012; still recruiting 14 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,600
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different iodine areas who underwent thyroid cancer surgery in branch hospitals from 2012 to 2019,and follow up their clinical outcomes. We aimed to analyse the relationship between regional iodine nutrition level and pathological types, clinical features, and prognosis of thyroid cancer.

Read the detailed description

Three sub centers were selected in high iodine (Jining/Liaocheng/Heze) and moderate iodine (Jinan/Shenyang/Haerbin) areas respectively. Patients lived in the above-mentioned regions for at least 5 years and diagnosed as thyroid cancer and underwent thyroid surgery in branch hospitals from 2012 to 2019 were recruited.

02

Conditions studied

  • Thyroid Cancer
03

In context

Thyroid Neoplasms

802 studies on the registry are indexed under Thyroid Neoplasms; 216 are open to participants now.

This study's planned enrollment of 1,600 is above the median of 172 across 261 observational studies indexed under Thyroid Neoplasms.

Browse Thyroid Neoplasms studies →

Lead sponsor

Shandong Provincial Hospital is the lead sponsor of 58 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Three sub centers were selected in high iodine (Jining/Liaocheng/Heze) and moderate iodine (Jinan/Shenyang/Haerbin) areas respectively. Patients lived in the above-mentioned regions at least for 5 years who was diagnosed as thyroid cancer and underwent thyroid surgery in branch hospitals from 2012 to 2019 were recruited.

Inclusion criteria

  1. Age range: 18\~65 years old, gender not limited;
  2. Living in the selected region for at least 5 years;
  3. Patients who underwent thyroid surgery at various research centers were pathologically diagnosed with thyroid cancer;
  4. The clinical data (general information、surgical scope 、pathological report、utrasonic report, etc )of the case is complete.

Exclusion criteria

Exclusion Criteria:

  1. Diagnosed as other types of cancer or thyroid metastatic cancer;
  2. There are serious comorbidities such as heart, liver, and kidney diseases present;
  3. Unable to follow up on prognostic information.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,600 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Excessive iodine group

    Residents with thyroid cancer who have lived in high iodine areas for a long time (5 years or more). According to the report of Shandong Institute of Endemic Disease Prevention and Control, three sub centers were selected in Excessive iodine group (Jining/Liaocheng/Heze).

    Dietary Supplement: Iodine excess

  • Suitable iodine group

    Residents with thyroid cancer who have lived in suitable iodine areas for a long time (5 years or more). According to the report of Shandong Institute of Endemic Disease Prevention and Control, three sub centers were selected in suitable iodine (Jinan/Shenyang/Haerbin) areas.

    Dietary Supplement: Iodine suitable

Interventions

  • Dietary supplementIodine excess

    Iodine excess areas: water iodine ≥100μg/L; or urinary iodine concentration (median urinary iodine levels in children aged 8-10 years old)≥300μg/L

  • Dietary supplementIodine suitable

    Iodine suitable areas:water iodine ≥40μg/L and ≤100μg/L; or urinary iodine concentration(median urinary iodine levels in children aged 8-10 years old) 100-199μg/L.

06

What researchers measure

Primary outcomes

  1. Number of participants with recurrence

    Recurrence: diagnosed as the same type of thyroid cancer again by pathology

    Time frame: from enrollment to the final follow-up at 5 years

  2. Number of participants with distant metastasis

    Distant metastasis: Pathological confirmed thyroid cancer occurring outside the thyroid gland

    Time frame: from enrollment to the final follow-up at 5 years

  3. All-cause mortality

    The ratio of the total number of deaths caused by various reasons during the research period to the number of participants

    Time frame: from enrollment to the final follow-up at 5 years

07

Study locations

1 of 1 sites recruiting
  • Shandong Provincial Hospital
    Jinan, Shandong 250021, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06623500
Lead sponsor
Shandong Provincial Hospital
Responsible party
Hai-qing Zhang (Chief physician, Shandong Provincial Hospital) — Principal investigator
First posted
Oct 2, 2024
Start date
Jan 1, 2012
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 2, 2024

Study contacts

Qingling Guo
Contact
guoqinglingqhb@163.com
+86 0531-68776375

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion